Securities Class Actions – Page 6 – ClaimsFiler

Case Type: Securities Class Actions

On September 27, 2024, AMMO, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Arizona on behalf of investors who purchased or otherwise acquired AMMO securities between August 19, 2020 and September 24, 2024, inclusive (the “Class Period”).

On September 27, 2024, Terran Orbital Corporation was sued for violations of the federal securities laws in the United States District Court for the Southern District of Florida on behalf of investors who purchased or otherwise acquired Terran securities between August 15, 2023 and August 14, 2024, both dates inclusive (the “Class Period”).

On September 26, 2024, Metagenomi Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased stock pursuant and/or traceable to Metagenomi’s registration statement for the initial public offering held between February 9 and 13, 2024

On September 24, 2024, Bumble Inc. was sued for violations of the federal securities laws in the United States District Court for the Western District of Texas on behalf of investors who purchased or otherwise acquired Bumble securities between November 7, 2023 and August 7, 2024, inclusive (the “Class Period”).

On September 20, 2024, Domino's Pizza, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Michigan on behalf of investors who purchased or otherwise acquired Domino’s securities between December 7, 2023 and July 17, 2024, both dates inclusive (the “Class Period”).

On September 17, 2024, New Fortress Energy Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired New Fortress securities between February 29, 2024 and August 8, 2024, inclusive (the “Class Period”).

On September 13, 2024, Allarity Therapeutics, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Allarity securities between May 17, 2022 and July 19, 2024, both dates inclusive (the “Class Period”).

On September 13, 2024, Coinbase Global, Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased or otherwise
acquired publicly traded Coinbase securities between April 14, 2021 and July 25, 2024, inclusive (the “Class Period”).

On September 9, 2024, Taro Pharmaceutical Industries Ltd. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of former shareholders of Taro Pharmaceutical Industries Ltd. in connection with the acquisition (the “Transaction”) of Taro by Sun Pharmaceutical Industries Ltd.

On September 6, 2024, Agenus Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Massachusetts on behalf of investors who purchased or otherwise acquired Agenus securities between January 23, 2023 and July 17, 2024, both dates inclusive (the “Class Period”).

On September 5, 2024, WEBTOON Entertainment Inc. was sued for violations of the federal securities laws in the United States District Court for the Central District of California on behalf of investors who purchased or otherwise acquired Webtoon common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s June 2024 initial public offering (“IPO” or
the “Offering”).

On September 4, 2024, ZoomInfo Technologies, Inc. was sued for violations of the federal securities laws in the United States District Court for the Western District of Washington on behalf of all purchasers of ZoomInfo Class A
common stock between November 10, 2020, and August 5, 2024, both dates inclusive (the “Class Period”).

On September 4, 2024, GitLab Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired GitLab securities between June 6, 2023 and March 4, 2024, inclusive (the “Class Period”).

On August 30, 2024, Migom Global Corp. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who, between December 6, 2019, and August 25, 2022, inclusive (the “Class Period”), purchased or otherwise acquired the securities of Migom Global Corp.

On August 30, 2024, Super Micro Computer, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased the Company’s securities between February 2, 2021 and August 28, 2024, inclusive (the “Class Period”).

On August 29, 2024, Outset Medical, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise
acquired Outset Medical securities between August 1, 2022 and August 7, 2024, inclusive (the “Class Period”).

On August 28, 2024, Starbucks Corporation was sued for violations of the federal securities laws in the United States District Court for the Western District of Washington on behalf of investors who purchased or otherwise acquired Starbucks securities between November 2, 2023 and April 30, 2024, inclusive (the “Class Period”).

On August 28, 2024, Sage Therapeutics was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired Sage securities between April 12, 2021 and July 23, 2024, both dates inclusive (the “Class Period”).

On August 27, 2024, Verve Therapeutics, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Massachusetts on behalf of investors who purchased or otherwise acquired publicly traded Verve Therapeutics securities between August 9, 2022 and April 1, 2024, inclusive (the “Class Period”).

We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.

OK